M&A Deal Summary |
|
|---|---|
| Date | 2008-08-12 |
| Target | Talecris Biotherapeutics Holdings Corp |
| Sector | Life Science |
| Buyer(s) | CSL |
| Sellers(s) |
Cerberus Capital Management
Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 3.1B USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1916 |
| Sector | Life Science |
| Employees | 27,000 |
| Revenue | 9.1B USD (2020) |
CSL is a manufacturer and marketer of pharmaceutical and diagnostic products, cell culture media and human plasma fractions. CSL was founded in 1916 and is based in Parkville, Australia.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (North Carolina) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-02-28 |
JRH Biosciences
Lenexa, United States JRH, headquartered in Lenexa, Kansas, has major manufacturing facilities and/or serum collection and processing centers in Caseyville, Illinois, Lenexa, Kansas, and Denver, Pennsylvania in the United States; Andover in the United Kingdom; and Brisbane and Brooklyn in Australia. JRH's product lines include sera, cell culture media used in the production of therapeutic proteins, reagent growth factors and biological material containers. JRH has approximately 400 employees. |
Sell | $370M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-06-02 |
Talecris Biotherapeutics Holdings Corp
Research Triangle Park, North Carolina, United States Talecris Biotherapeutics Holdings Corp. is a pharmaceutical Development and Manufacturing company. |
Sell | - |
| Category | Asset Manager |
|---|---|
| Founded | 1992 |
| PE ASSETS | 55.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Cerberus Capital Management is a private investment firm that targets a wide range of global investments. Cerberus primarily looks for undervalued or distressed situations. Industry sectors of interest include aerospace and defense, apparel, automotive and industrial, building products, commercial services, consumer and retail, financial services, healthcare, manufacturing and distribution, paper, packaging, and printing, real estate, technology, telecommunications, transportation, and travel. In addition to private equity investing, Cerberus also provides corporate credit and acquires real estate. Cerberus was formed in 1992 by Steve Feinberg and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 54 |
| Sector (Life Science) | 1 of 3 |
| Type (Add-on Acquisition) | 1 of 27 |
| State (North Carolina) | 1 of 4 |
| Country (United States) | 3 of 36 |
| Year (2008) | 1 of 2 |
| Size (of disclosed) | 2 of 14 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-04-01 |
Advantage Resourcing America
Tokyo, Japan Advantage is a member of a family of Staffing companies owned by parent Recruit Holdings Co., Ltd., based in Tokyo Japan. Advantage has offices in the U.S., Canada, UK and Sydney Australia. The Advantage service delivery model is “local market focus”, meaning that Advantage learns client requirements for primary skill sets in every local market we serve. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-10-17 |
Mervyn s
Hayward, California, United States Mervyn's was a retail department store that was formed in 1949. The retail chain featured national brands and carried a broad selection of items - from apparel to electronics. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 53 |
| Sector (Life Science) | 2 of 24 |
| Type (Add-on Acquisition) | 5 of 38 |
| State (North Carolina) | 2 of 4 |
| Country (United States) | 8 of 50 |
| Year (2008) | 1 of 1 |
| Size (of disclosed) | 1 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-01-23 |
Signature Genomic Laboratories
Spokane, Washington, United States Signature Genomic Laboratories, LLC is a provider of microarray-based cytogenetic diagnostics with its proprietary SignatureChip and is the major in providing microarray-based chromosome analysis. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-29 |
MedVenture Technology
Jeffersonville, Indiana, United States MedVenture Technology Corp. is a outsourced developer and manufacturer of disposable medical devices. |
Buy | - |
